Paul Herzich
Chief Tech/Sci/R&D Officer at SOLID BIOSCIENCES INC.
Net worth: 51 428 $ as of 30/04/2024
Paul Herzich active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SOLID BIOSCIENCES INC. | Chief Tech/Sci/R&D Officer | 01/12/2022 | - |
Career history of Paul Herzich
Former positions of Paul Herzich
| Companies | Position | Start | End |
|---|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Chief Tech/Sci/R&D Officer | 01/04/2021 | 01/12/2022 |
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01/08/2020 | 01/04/2021 |
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2018 | 01/07/2019 |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Corporate Officer/Principal | 01/08/2016 | 01/01/2018 |
| Csl Seqirus | Corporate Officer/Principal | 01/12/2007 | 01/07/2015 |
Training of Paul Herzich
| Rutgers State University of New Jersey | Undergraduate Degree |
| Poole College of Management | Masters Business Admin |
Statistics
International
| United States | 8 |
| France | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SOLID BIOSCIENCES INC. | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
| Csl Seqirus |
- Stock Market
- Insiders
- Paul Herzich
- Experience
